A novel TCR-like CAR with specificity for PR1/HLA-A2 effectively targets myeloid leukemia in vitro when expressed in human adult peripheral blood and cord blood T cells-Reference-Cited by-同舟云学术

A novel TCR-like CAR with specificity for PR1/HLA-A2 effectively targets myeloid leukemia in vitro when expressed in human adult peripheral blood and cord blood T cells

Published:2016-08 Issue:8 Volume:18 Page:985-994
ISSN:1465-3249
Container-title:Cytotherapy
language:en
Short-container-title:Cytotherapy

Author:

Ma Qing,Garber Haven R.,Lu Sijie,He Hong,Tallis Eran,Ding Xiaoling,Sergeeva Anna,Wood Michael S.,Dotti Gianpietro,Salvado Barbara,Ruisaard Kathryn,Clise-Dwyer Karen,John Lisa St,Rezvani Katayoun,Alatrash Gheath,Shpall Elizabeth J.,Molldrem Jeffrey J.

Funder

National Cancer Institute

Leukemia and Lymphoma Society

Publisher

Elsevier BV

Subject

Cancer Research,Transplantation,Cell Biology,Genetics (clinical),Oncology,Immunology,Immunology and Allergy

Reference47 articles.

1. Chimeric antigen receptor T cells for sustained remissions in leukemia;Maude;N Engl J Med,2014

2. Efficacy and toxicity management of 19-28z CAR T cell therapy in B cell acute lymphoblastic leukemia;Davila;Sci Transl Med,2014

3. Acute Myeloid Leukemia;Dohner;N Engl J Med,2015

4. Targeted T-cell therapy for human leukemia: cytotoxic T lymphocytes specific for a peptide derived from proteinase 3 preferentially lyse human myeloid leukemia cells;Molldrem;Blood,1996

5. Cytotoxic T lymphocytes specific for a nonpolymorphic proteinase 3 peptide preferentially inhibit chronic myeloid leukemia colony-forming units;Molldrem;Blood,1997

Cited by 76 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent updates on allogeneic CAR-T cells in hematological malignancies;Cancer Cell International;2024-09-03

2. Hu8F4-CAR T cells with mutated Fc spacer segment improve target specificity and mediate anti-leukemia activity in vivo;Cytotherapy;2024-07

3. Placental circulating T cells: a novel, allogeneic CAR-T cell platform with preserved T-cell stemness, more favorable cytokine profile, and durable efficacy compared to adult PBMC-derived CAR-T;Journal for ImmunoTherapy of Cancer;2024-04

4. Preclinical evaluation of a novel CAR-T therapy utilizing a scFv antibody highly specific to MAGE-A4p230-239/HLA-A∗02:01 complex;Molecular Therapy;2024-03

5. Hu8F4-CAR T cells with mutated Fc spacer segment improve target-specificity and mediate anti-leukemia activity in vivo;2024-02-19